SEC Form 4 · accession 0001209191-17-059523
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles McWherter
Officer — SVP & Chief Scientific Officer
Period of report
Nov 2, 2017
Accepted (ET)
Nov 6, 2017 · 8:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2017 | P | 300 | $8.67 | A | 10,300 | D | |
| Common Stock | Nov 2, 2017 | P | 4,700 | $8.668 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.